Skip to results
Modify your search
NARROW
1-20 of 68
Authors: Alberto Aimo
Journal Article
Cardiac amyloidosis: Innovations in diagnosis and treatment
European Heart Journal Supplements, Volume 27, Issue Supplement_1, February 2025, Pages i88–i97, https://doi.org/10.1093/eurheartjsupp/suae111
Published: 19 February 2025
Journal Article
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis Get access
European Heart Journal - Cardiovascular Imaging, Volume 26, Issue 3, March 2025, Pages 500–508, https://doi.org/10.1093/ehjci/jeae332
Published: 23 December 2024
Journal Article
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis Get access
European Journal of Preventive Cardiology, zwae297, https://doi.org/10.1093/eurjpc/zwae297
Published: 23 September 2024
Journal Article
Colchicine in acutely decompensated heart failure: the COLICA trial
European Heart Journal, Volume 45, Issue 45, 1 December 2024, Pages 4826–4836, https://doi.org/10.1093/eurheartj/ehae538
Published: 30 August 2024
Journal Article
Assessing cardiac mechanics through left ventricular haemodynamic forces
European Heart Journal - Imaging Methods and Practice, Volume 2, Issue 3, July 2024, qyae077, https://doi.org/10.1093/ehjimp/qyae077
Published: 25 July 2024
Journal Article
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) scientific statement on the simplification of the drug regimen for secondary cardiovascular prevention
European Heart Journal Supplements, Volume 26, Issue Supplement_2, April 2024, Pages ii236–ii251, https://doi.org/10.1093/eurheartjsupp/suae032
Published: 16 May 2024
Journal Article
EDITOR'S CHOICE
Use of new and emerging cancer drugs: what the cardiologist needs to know
European Heart Journal, Volume 45, Issue 22, 7 June 2024, Pages 1971–1987, https://doi.org/10.1093/eurheartj/ehae161
Published: 09 April 2024
Journal Article
EDITOR'S CHOICE
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis
European Heart Journal - Cardiovascular Imaging, Volume 25, Issue 7, July 2024, Pages 1007–1017, https://doi.org/10.1093/ehjci/jeae060
Published: 18 March 2024
Journal Article
EDITOR'S CHOICE
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study
European Journal of Preventive Cardiology, Volume 31, Issue 11, August 2024, Pages 1410–1417, https://doi.org/10.1093/eurjpc/zwae093
Published: 08 March 2024
Journal Article
Clinical and prognostic implications of left ventricular dilatation in heart failure
European Heart Journal - Cardiovascular Imaging, Volume 25, Issue 6, June 2024, Pages 849–856, https://doi.org/10.1093/ehjci/jeae025
Published: 21 January 2024
Journal Article
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis
European Heart Journal - Cardiovascular Imaging, Volume 24, Issue 10, October 2023, Pages 1405–1414, https://doi.org/10.1093/ehjci/jead145
Published: 28 June 2023
Journal Article
Critical Reading of cardiovascular trials with neutral or negative results
European Heart Journal, Volume 44, Issue 40, 21 October 2023, Pages 4230–4232, https://doi.org/10.1093/eurheartj/ehad353
Published: 22 June 2023
Journal Article
ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy
European Heart Journal Supplements, Volume 25, Issue Supplement_D, May 2023, Pages D278–D286, https://doi.org/10.1093/eurheartjsupp/suad106
Published: 18 May 2023
Journal Article
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
European Heart Journal Supplements, Volume 25, Issue Supplement_B, April 2023, Pages B79–B84, https://doi.org/10.1093/eurheartjsupp/suad079
Published: 21 April 2023
Journal Article
267 EFFECTS OF PIRFENIDONE ON SCAR SIZE AND VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION: A PRECLINICAL STUDY
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.142, https://doi.org/10.1093/eurheartjsupp/suac121.142
Published: 15 December 2022
Journal Article
557 RAREFACTION OF MYOCARDIAL LYMPHATIC VESSELS IN PATIENTS WITH CARDIAC AMYLOIDOSIS
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.580, https://doi.org/10.1093/eurheartjsupp/suac121.580
Published: 15 December 2022
Journal Article
1111 INTACT FIBROBLAST GROWTH FACTOR 23 TESTED BY A FULLY AUTOMATED ASSAY: CLINICAL CORRELATES AND PROGNOSTIC VALUE IN CHRONIC SYSTOLIC HEART FAILURE
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.440, https://doi.org/10.1093/eurheartjsupp/suac121.440
Published: 15 December 2022
Journal Article
269 EFFECTS OF COLCHICINE TREATMENT AFTER MYOCARDIAL INFARCTION ON TOP OF STANDARD THERAPY: EVIDENCE FROM A PRECLINICAL STUDY
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.493, https://doi.org/10.1093/eurheartjsupp/suac121.493
Published: 15 December 2022
Journal Article
1107 PLASMA CIRCULATING TRANSTHYRETIN FORMS IN PATIENTS WITH WILD TYPE TRANSTHYRETIN CARDIAC AMYLOIDOSIS
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.596, https://doi.org/10.1093/eurheartjsupp/suac121.596
Published: 15 December 2022
Journal Article
490 NT-PROBNP AND HIGH-SENSITIVITY TROPONIN T HOLD DIAGNOSTIC VALUE IN CARDIAC AMYLOIDOSIS
European Heart Journal Supplements, Volume 24, Issue Supplement_K, December 2022, suac121.594, https://doi.org/10.1093/eurheartjsupp/suac121.594
Published: 15 December 2022
